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Introduction
Approximately 50% of plasma calcium is present as the
physiologically active ’ionized’ or ’free’ form. Although routine
clinical assessment of this fraction is usually made from
knowledge ofthe total calcium, total protein and albumin, there
is increasing evidence that in pathological situations this
approach does not correlate well with the direct measurement of
ionized calcium [1].
This study was undertaken to investigate the performance of
a new ionized calcium analyser, the ’Nova 2’, and determine its
practicability in the routine clinical laboratory.
Materials and methods
The Nova 2 analyser (Nova Biomedical, Newton,
Massachusetts, USA) is an automatic instrument that measures
ionized calcium by direct potentiometry. It was used according
to the manufacturer’s instructions and with the reagents and
standards supplied. The data reported here was gathered over a
period of five months. Because of the unavailability of a
commercial control serum for ionized calcium, one was pre-
pared in the following way: pooled serum was collected from
normal individuals and first allowed to equilibrate with the
atmosphere, then buffered with 10mmol/l Tris/HC1 at pH 7"4,
The total calcium was 2"3 mmol/l (Control A).
A second pool was prepared in a similar way, but CaCI2 was
added to yield a total calcium of 3"3 mmol/1 (Control B). These
control sera were aliquoted and stored deep frozen at -80C.
Total calcium and total protein were measured on a Dupont
ACA (Wilmington, Delaware, USA) and an Abbott ABA-100
(Chicago, Illinois, USA) respectively. Albumin was quantitated
by electrophoresis on cellulose acetate [2]. Corrected calcium
(in mmol/l) was calculated as follows:
(A) Total protein correction [3]:
Corrected measured calcium calcium
[ 0"4xTP(g/1).l 0"64
74
(B) Albumin correction [4]:
Corrected calcium measured
calcium+ 0"025[albumin (g/l)- 40].
In all experiments involving serum, plasma or whole blood
samples, strict anaerobiasis was maintained, either by direct
sampling from vacutainers, or storage of samples in capped
syringes with direct introduction into the analyser probe using a
short length ofplastic tubing. Samples from patients undergoing
plasmapheresis were taken immediately before and after the
procedure itself.
* Present address: Department of Pediatrics, University of Alberta
Hospital, Edmonton, Alberta T6G 2B7, Canada.
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Results
Precision
When replicate serum analyses were performed sequentially the
results progressively decreased. This effect could be prevented
by preceding each serum analysis with an aqueous standard.
This effect was not appreciated until about one-third of the way
through the project, which could partly explain why the control
values up to this point tended to be lower than those recorded
later. It would also explain the improved precision after this time
when the above procedure was carried out routinely. (All
patients’ results reported in this study were preceded by aqueous
standards.) Precision improved when serum or plasma was used
rather than whole blood on patient samples; however, precision
was worse using control serum than with patient samples (table
1).
Accuracy
Samplin9 methods
The analyser is designed to sample anaerobically whole blood,
plasma, or serum directly from a vacutainer or syringe.
However, the analyser tubing is made from silicone rubber
which is carbon dioxide-permeable and therefore could allow
significant CO2 loss and consequent pH and ionized calcium
changes [5]. This was demonstrated by replacing the tubing
with CO2 impermeable material (polypropylene). The result was
a slight, but significant, rise in the mean of results by
0"015 mmol/1 (p <0.01).
Table 1. Precision.
Mean SD CV
N (mmol/l) (mmol/1) (%)
(a) Within-run
Aqueous standards:
0"5 mmol/1 21 0.492 0.004 0"87
1"5 mmol/1 46 1.502 0"009 0"57
2.5 mmol/1 19 2"557 0"017 0.65
Control sera: A 17 1.330 0"016 1"22
B 17 1.958 0.039 2"00
Patient samples:
Whole blood 17 1" 183 0"014 1.18
Plasma 12 1" 120 (003 0"23
Duplicate sera 64 1.150 0"007 0"62
(b) Between-run
All data:
Control A 56 1"345 0’023 1"71
Control B 57 1.997 0"046 2"30
Later data only*:
Control A 34 1-357 0"014 1"03
Control B 35 2.017 0"029 1.44
* After the policy was instituted ofpreceding each serum analysis with an
aqueous standard.Whole blood versus plasma
This was investigated on five separate occasions by running
replicate analyses on whole blood and anaerobically-separated
plasma from the same individual. The results were inconsistent;
on two days there was less than 0.010mmol/1 difference
(p >0.05), but on three other occasions the results were higher
on the whole blood samples by 0.070mmol/1 (p<0"01),
0.066mmol/l (p<0"001), and 0.086mmol/1 (p<0"001).
Serum versus plasma
No statistically significant difference could be found between
results on serum and plasma when each was sampled from
standard vacutainers. (Heparin concentration of plasma
approximately 25 units/ml.) However, a higher concentration of
heparin, typically that used in blood gas analysis (approximately
200-400 units per ml), was found to depress results by a mean of
8 (p<0"001). It is important to fill vacutainers completely;
vacutainers which were only half full gave results on average3
lower than full ones.
Effect of changing electrodes
Fifteen patient sera were run on each of two electrodes..A
marked difference in results were obtained, despite successful
aqueous calibration in each case (table 2). Care was taken to
keep the samples anaerobic and to avoid any timing bias: half
the samples were run on electrode A, the electrodes ,were
switched, all were run on B, then the other half run on A.
Table 2. Effect of changing electrode on ionized calcium
results.
Mean* SD
(mmol/l) (mmol/1)
Electrode A 1-272 0"236
Electrode B 1.199 0.237
Difference (A-B) 0.072 0"009 (p= < 0001)
N-15 patient sera.
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Table 3. Ionic interferences.
Interfering Concentration Mean
ion range studied interference
(Apparent change in
ionized calcium)
pH 6.77-8.00
Mg+ + 1-5 mmol/l
Na 100-175 mmol/1
-0"007 mmolfl ionized
calcium per 0" pH
unit increase
-0.066 mmol/1 ionized
calcium per mmol/1
Mg+ + increase
-0"012 mmol/l ionized
calcium per 10mmol/l
Na+ increase
1.40
1.3o
._-2
-5 1.20
" 1.10
1.00
0.90
Protein-rich retentate
Serum
Ultrafiltrate
b 4’o go io
Total protein (g/I)
Figure 1. Effect of protein concentration on apparent
ionized calcium measured on the Nova 2 analyser. Four sera
(1-4) were anaerobically ultrafiltered at 37C to yield the
fractions shown.
Normal range
This was established on venous plasma samples of 17 normal
individuals of both sexes and aged between 18 and 40. Mean
1"204 mmol/1, SD 0.047 mmol/1; mean+ 2 SD 1.11 0-1.298
mmol/1.
Ionic interferences
Interference was tested on aqueous calcium chloride solutions
that were buffered with 5 mmol/l Tris-HC (pH 7-4 except in pH
studies). Results were plotted against several concentrations of
added ions and mean interferences calculated from the re-
gression line slopes. All plots were reasonably linear. The data
are summarized in table 3.
Protein interference
Four patient sera were anaerobically ultrafiltered at 37C using
Worthington ’Ultrafree’ filters. When analysed using the Nova
2, the apparent ionized calcium was lower in the ultrafiltrate,
and higher in the protein-rich serum remaining after ultra-
filtration, with the native serum results in between (figure 1).
There was also a significant correlation observed between
ionized calcium and total protein (r 0.36, p <0.001) in a group
of 78 hospital patients with miscellaneous complaints. The
regression line slope was 0.0049mmol/l of ionized calcium
per g/1 protein.
Comparison with total calcium results
There is a good overall correlation (r- 0.89) with total calcium
in the patients studied (figure 2). Interestingly, the correlation
coefficient is lower when the total calcium is corrected for
albumin (r=0.57) or total protein (r=0.66).
Patients undergoing plasmapheresis all showed a consistent
decrease in both ionized and total calcium, though the fall in the
ionized fraction was proportionally greater (table 4).
Reliability
No major instrument problems developed during this evalu-
ation. Preventative maintenance is well explained in the
manufacturer’s manual and easy to perform. Tubing tended to
become blocked if left in the ’stand-by mode’ for more than one
day. This can be avoided by using the ’stat mode’, which is rather
expensive on reagents, or by calibrating the instrument at least
twice daily in the ’stand-by mode’.
Discussion
Within-run and between-run precision is acceptable, but it is
recommended that all serum analysis be preceded by aqueous
standards in order to achieve optimum performance. The reason
for poorer precision using control serum rather than patient
samples is not clear.
Whole blood samples give poorer precision and do not
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Figure 2. ’Scattergram’ of ionized calcium versus total
calcium. Different 9roups of patients are identified.
Enclosed horizontal and vertical lines represent normal
range limits. Correlation coefficient (r)=0"89.
Table 4. Ionized calcium in 17 plasmapheresis patients
(mean +_ SO).
Pre Post Significance*
Ionized calcium
(mmol/1) 1.14+ 0"09 0"99 _+ 0.08 p< 0"001
Total calcium
(mmol/1) 2-21 +0.12 1-99+0-10 p<0.001
Albumin corrected
total calcium
(mmol/l) 2.27+0"14 2.03+0"09 p<0.001
Total protein
corrected total
calcium (mmol/l) 2"43 +0"09 2.37 +0.09 p-- 0.04
Total protein (g/l) 58.4+__8"6 44.6+4.2 p<0"001
Albumin (g/l) 38"0+ 5"5 38-1 +__ 2.5 N.S.
Paired Student’s t-test.
correlate well with plasma results. Most previous authors using
both the Orion SS-20 [5-7] and the Nova 2 [8] have found
increased values in whole blood, but in one study the difference
was minimal [9]. Increased values could be explained by red
cells altering the potential at the liquid junction [5 and 7].
Exactly why the results in this study were variable from day to
day is difficult to explain. The liquid junction in the Nova 2 is
situated within the reference electrode, and it is possible that
build-up of potassium chloride crystals might alter the charac-
teristics of the liquid junction from day to day, without blocking
the flow completely.
Serum protein may also alter the residualjunction potential,
and has been reported to cause positive interference in the
measurement ofionized calcium [5 and 7]. This study suggests a
similar problem: when protein was separated by ultrafiltration,
the apparent ionized calcium fell more than the approximately
5 anticipated from the Donnan effect [10]. Also, the corre-
lation observed between ionized calcium and protein levels in
patient samples tends to confirm this hypothesis. Ionic inter-
ferences with the exception of magnesium are minimal. The
discrepancy between the negative interference reported here and
the positive interference reported by Fyffe et al. [8] is difficult to
explain unless individual electrodes vary widely in their re-
sponses. There appears to be a negative bias introduced by the
carbon dioxide permeability of silicone rubber tubing; however,
this is likely to be fairly constant and its minor extent makes it of
little clinical importance.A more important source oferror is the
variability in results between electrodes, which has also been
reported in previous studies ofthe Nova [8], as well as the Orion
SS-20 [5]. If this is a regular and expected occurrence, then the
normal range would have to be checked and possibly changed
with each new electrode that was used, unless it could be shown
that the difference in control serum values accurately parallelled
those of patient samples and results are corrected
accordingly [5].
In the patients studied, ionized calcium levels showed a good
correlation with total calcium, similar to previous published
studies [11]. In theory, one would expect the correlation to
improve iftotal calcium is corrected for albumin or total protein
levels. The fact that this does not happen is consistent with other
reports that ’correction factors’ do not actually work well in
practice [1].
Patients undergoing plasmapheresis show a marked drop in
ionized and total calcium, with a proportionally greater fall in
the former. This is similar to the results reported by Morse et al.
[12]. A few patients experienced symptoms of hypocalcemia,
such as circumoral paresthesia. This probably related to the use
of citrate as an anticoagulant which complexes ionic calcium.
However, the low protein level post-plasmapheresis could also
lead to artifactually low measured ionized calcium levels
(c.f. protein effect, above). Patients on total parenteral nutrition
have unremarkable ionized calcium concentration, being either
within or near the normal range.
Conclusion
Generally, this is a very simple instrument to operate, which gives
reproducible results given a few simple precautions. Direct
serum sampling from vacutainers is a very convenient way to
introduce anaerobic samples. This instrument is a definite
advance over previous instruments and should make routine
measurement of ionized calcium more readily available for the
clinical laboratory.
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